Back to Top

Information For Authors

Submitting Your Manuscript

Journal of Interferon & Cytokine Research publishes original articles in the following formats: research reports, review articles, short reports, rapid communications, and correspondence, covering all aspects of interferon and cytokine research ranging from the molecular biology of interferon and cytokine systems to their use in the clinic.

Expedited Peer Review

An option for an expedited peer-review process is available in which a final decision including the referees' critiques will be forwarded to the corresponding author within a three-week period from the receipt of the completed manuscript at the editorial office. The cost for this service is $250.00 and is paid by the corresponding author. A payment window will appear when all files have been downloaded. We accept American Express/Optima, VISA, and MasterCard.


The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Journal of Interferon & Cytokine Research before logging in with an ORCID identifier.

Manuscript Submission Site

Create an Account in ScholarOne

If you do not already have an account in ScholarOne for Journal of Interferon & Cytokine Research, you will need to create one.  Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.



Check the Journal’s PEER REVIEW POLICIES

Manuscript Preparation

Determining Authorship


JICR will no longer consider manuscripts submitted by a third-party service or agency. All manuscripts must be submitted directly by the corresponding or submitting author.

All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.

All authors are deemed to be individually and collectively responsible for the content of manuscripts and must acknowledge their approval of the submitted manuscript. Citations for personal communication and other contributions not recognized by authorship are also subject to this expectation.

It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors' names and affiliations upon original submission of the manuscript.

Submission Process


  • An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
  • Acknowledgments section (if applicable) after the Conclusion of the paper, followed by
  • An Author Contribution statement for each listed author, followed by
  • An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
  • Funding statement(s), even if there is no funding information to declare.




Human Subjects: Patient Consent/Release

If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form. Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.

In keeping with patients' rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests that they have received and archived written patient consent.

All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

When submitting your manuscript for peer review, be prepared to:

  • Enter the full title of the manuscript
  • Enter the full names and institutional affiliations of ALL listed authors
  • Enter ALL listed authors' institutional email addresses
  • Identify the corresponding author
  • Enter a running (abbreviated) title of no more than 40 characters (including spaces).
  • Enter 3–6 keywords or phrases.
  • Provide an unstructured abstract of no more than 200 words stating the aims, results, and conclusions drawn from the study. Reference citations are not permitted in the abstract.
  • Provide the names and email addresses of at least five potential preferred reviewers familiar with the field.  Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated.  Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer.   Ultimate reviewer selection is at the Editor’s discretion.
  • Confirm that the material has not been published or submitted for publication elsewhere

Create an Effective Title

  • Manuscript titles should be brief, contain key terms, and clearly identify the purpose
  • of the work conducted
  • Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
  • Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
  • Avoid the use of specific locations in the title
  • Do not use proprietary/trademarked names in the title
  • Do not use acronyms in the title unless they are universally recognized and accepted
  • NOTE: The title page of your submission must be included as part of your main text document (not as a separate file). 

File Naming

All file names should be in English and contain only alphanumeric characters.  Do not include spaces, symbols, special characters, dashes, dots, or underscores.  Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)

Important:  Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.  

Preparation of Manuscript

Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:

  • Title page (with full manuscript title, all contributing authors and their affiliations, a short running title, a denotation of the corresponding author, and a list of 3-6 keywords). Author affiliations should include department, institution, and complete address, with the ZIP/postal code, for each author. Use superscripts to match authors with institutions.
  •  Abstract
  •   Main text (do not embed figures or tables)
  •  Conclusion (as a separate paragraph, not as part of the Discussion section)
  •   Acknowledgments (if applicable)
  •   Authorship confirmation statement (see below)
  •   Author(s’) disclosure statement(s) (see below)
  •   Funding statement (see below)
  •   References
  •   Figure legends
  •   Tables
  •   Supplemental files (if applicable; if the submission is accepted, supplemental files will be published as supplied, without copyediting or typesetting)

Manuscript Text

Maximum word count for original articles should not exceed 3,000 words.  In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, and Conclusions. All pages and lines are to be numbered. Include the first author's name on each page. Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors & Editors or the Council of Biology Editors Style Manual, 10/e. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses. Authors should provide the name of the manufacturer and their location (town/city, state [if in the U.S.], and country) for any specifically named medical equipment and instruments.


The Introduction should assume that the reader is knowledgeable in the field and should therefore be as brief as possible but can include a short historical review where desirable.

Materials and Methods

This section should contain sufficient detail, so that all experimental procedures can be reproduced, and include references. Methods, however, that have been published in detail elsewhere should not be described in detail.


The Results section should briefly present the experimental data in text, tables, or figures. Tables and figures should not be described extensively in the text, either.


The discussion should focus on the interpretation and the significance of the findings with concise objective comments that describe their relation to other work in the area. It should not repeat information in the results. The final paragraph should highlight the main conclusion(s), and provide some indication of the direction that future research should take.


These should be brief, and should include sources of support including sponsorship (e.g. university, charity, commercial organization) and sources of material (e.g. novel drugs) not available commercially.


References must be prepared in Word, double spaced, and listed alphabetically. Include the reference section as part of the main text file, not as a separate file. A complete list of authors, titles, and page numbers must be included in each reference. Each reference must be cited in the text and listed in parentheses with the author’s last name and year of publication; see examples below. Three or more authors should be listed as (Author et al 2020).

Use journal abbreviations as provided by PubMed/Medline. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication). When data from an unpublished source are given, supply complete information, e.g., the researcher's name and location. Written permission must be obtained from the author of any unpublished material cited from other laboratories and for personal communications and should accompany the manuscript. Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.

Sample style for references:

    Journal article:

Conlon KC, Miljkovic MD, Waldmann TA. Cytokines in the treatment of cancer. J Interferon Cytokine Res 2019;39(1):6-21.  

In-text: (Conlon et al 2019)


Cossart P, Boquet P, Normark S, Rappuoli R, eds. Cellular Microbiology, 2nd ed. Washington, DC: ASM Press; 2005.

In-text: (Cossart et al 2005)

    Chapter in a book:      

McDaniel TK, Valdivia RH. New tools for virulence gene discovery. In: Cossart P, Boquet P, Normark S, Rappuoli R, eds. Cellular Microbiology, 2nd ed. Washington, DC: ASM Press; 2005, pp 473–488.

In-text: (McDaniel and Valdivia 2005)

Figure Legends

Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the figure is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section. All permission listings must be included in the submitted manuscript—they cannot be entered on proofs.


All tables should be prepared in one single Word file. Provide a title for each table. Use Arabic numerals to number tables. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Information that appears in the text should not be repeated in tables, and tables should not contain data that can be given in the text in one or two sentences. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section. All permission listings must be included in the submitted manuscript—they cannot be entered on proofs.


  • Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
  • Figures should not be embedded within the manuscript file.
  • Cite figures consecutively in text within parentheses.
  • A legend should be supplied for each figure and all legends numbered consecutively.
  • Images should not show the name of a patient or a manufacturer.  
  • Do not include any illustrations as part of your text file.

Color Figures

Color figures submitted for peer review are expected to be published in color. Authors should determine that the use of color is essential prior to submission, and the cost for color printing must be subsidized by the author(s). Price estimates are available from the Publisher upon request. Please consider these expenditures when preparing your manuscript for submission

Visual Abstract

Visual abstracts (VAs) allow readers to analyze quickly the main purpose of an article and assist in the identification of articles that are most relevant to their interests or areas of research. They are designed to promote interdisciplinary scholarship and to increase the visibility of one’s work in search engines. Authors are encouraged to submit an image (visual abstract) that clearly outlines the work described in the manuscript. For those who are not able to supply a visual abstract themselves, the Publisher can provide one at a cost of $200 USD per visual abstract. Contact for more information.

Please, follow these criteria when preparing and uploading visual abstracts:

  • Prepare the image in .TIFF, EPS, or PowerPoint format. Avoid submitting .JPEG or PDF files. The image should be clear and uncluttered
  • .The organization of elements within the visual abstract should read from left to right.
  •  Submit at a minimum of 300 dpi.
  •  The image size must be approximately 7.5 x 4 inches (19 x 10 cm; 720 x 385 pixels). Images may need to be scaled slightly to fit the available window.
  • Use a sans serif font (ex: Arial, Calibri, Tahoma, Verdana) or symbol, in 12- or 13-point typeface.
  • Do not include large amounts of narrative text in the visual abstract.
  • Minimize the amount of white space whenever possible.
  • Submit simultaneously with the submission of the full manuscript.
  • Upload the file and select “Visual Abstract" as the file designation from the drop-down list when submitting all other manuscript files.
  • The publisher will insert the journal logo within the visual abstract and will also insert the article’s unique DOI number at the bottom of the image.
  • It is important to create your own image(s) or use copyright-free images that do not require permission, unless you attribute the source. All images should be checked for accuracy. Below is a list of databases and libraries that offer non-copyrighted/free images. Mary Ann Liebert, Inc., does not have any connection to or responsibility for these websites.

NIH Images from the History of Medicine

NIH Images and B-roll

National Library of Medicine

NCI Visuals Online

CDC Public Health Image Library

Health on the Net Foundation

Health Education Assets Library

Servier Medical Art 

SCIRO Science Image 


Correspondence Address

Following the references, provide the name and complete affiliation, address, telephone number, and institutional email address of the person to whom correspondence should be sent.

Manuscript Revisions

To upload a revision of a manuscript, the submitting author should log in to their Author Center at and click on “Revised Manuscripts in Draft.”  All revised submissions will be required to meet all formatting conditions described herein.  Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.

Letters to the Editor

Journal of Interferon & Cytokine Research will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.

Journal Policies on:

Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Publication Costs
Archiving and Preservation
Publisher Information

For questions regarding manuscript submissions, contact our Author Services Division.


Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Society Affiliations

Upcoming Events

Nov 01 - Nov 04, 2020